You are here: Industry Insights > cancer

News List

Mortality Risk in Oropharynx Cancer Varies Based on HPV Status drugs
January 20, 2020
For patients with oropharynx cancer, the rates of head and neck cancer (HNC) mortality and competing mortality vary depending on human papillomavirus (HPV) status, with increased risks for HNC mortality and competing mortality in HPV-negative patients ...
Colorectal Cancer Risk Still Up in Patients With Ulcerative Colitis drugs
January 19, 2020
Patients with ulcerative colitis have an increased risk for colorectal cancer and colorectal cancer mortality, according to a study published in the January issue of?The Lancet.
B cells linked to effective cancer immunotherapy worldpharmanews
January 19, 2020
Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden.
NICE recommends olaparib tablets for platinum-sensitive cancer patients europeanpharmaceuticalreview
January 19, 2020
NICE has recommended olaparib tablets (Lynparza, AstraZeneca) for adults with relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer with a BRCA1 or BRCA2 mutation.
SOTIO Opens Office in Basel, Switzerland, to Accelerate Development of its Pipeline Products b3cnewswire
January 17, 2020
SOTIO, a biotechnology company owned by the PPF Group, announce the opening of offices of SOTIO Biotech AG at the Technology Park Basel, Switzerland.
Increasing Vegetable Intake Does Not Slow Prostate Cancer drugs
January 17, 2020
A behavioral intervention that increases vegetable consumption does not reduce the risk for progression of early-stage prostate cancer, according to a study published in the January issue of the?Journal of the American Medical Association.
Astellas, Adaptimmune sign deal to co-develop T-cell therapies for cancer pharmaceutical-business-review
January 17, 2020
Astellas Pharma has signed a deal worth up to $897.5m with Adaptimmune Therapeutics to co-develop and co-commercialise stem-cell derived allogeneic CAR-T and TCR T-cell therapies for cancer.
NICE requests more data on Keytruda for head and neck cancer treatment europeanpharmaceuticalreview
January 17, 2020
NICE has asked for more information on Keytruda (pembrolizumab) for untreated metastatic or unresectable recurrent squamous cell head and neck cancer due to uncertainty over clinical trial evidence.
Weight Control Drug Lorcaserin May Raise Cancer Risk drugs
January 16, 2020
The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the risk for cancer, according to the results of a clinical trial assessing the safety of the drug, the U.S. Food and Drug Administration says.
FDA issues alert for cancer risk from Belviq (lorcaserin) europeanpharmaceuticalreview
January 16, 2020
The US FDA has announced a warning to healthcare professionals and patients that the weight management drug Belviq may be a cause of cancer.